Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine to Reduce Dysphagia After Anterior Cervical Discectomy and Fusion Surgery
NCT02376205Completed
- Sponsor
- Justin Parker Neurological Institute
- Start
- Feb 2015
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine in dysphagia (2 arms), sponsored by Justin Parker Neurological Institute. Primary endpoint: Reduction in dysphagia scores at 3 months. Started Feb 2015; status: completed.
02
Drugs
bupivacaine
03
Conditions
dysphagia
Beyond the preview
Go deeper on NCT02376205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02376205.